.
LPL - PRODUCTION TEST COLLECTION
         CENTRE
         SECTOR - 18, BLOCK-E ROHINI
         DELHI 110085
         Name             :        Dummy-F001                                                   Collected       : 22/3/2018 7:34:00AM
                                                                                                Received        : 22/3/2018 3:59:43PM
         Lab No.          :    LPLT12358        Age: 28 Years              Gender:     Female   Reported        : 26/3/2018 1:35:03PM
         A/c Status       :    P                Ref By :    ------------                        Report Status   :
         Test Name                                                           Results              Units                 Bio. Ref. Interval
         AFP (ALPHA FETOPROTEIN), TUMOR MARKER,                                                   ng/mL                 <10.00
         SERUM
         (CMIA)
         Note
           1.        This test is not recommended to screen cancers in the general population.
           2.        False negative/positive results are observed in patients receiving mouse monoclonal
                     antibodies for diagnosis or therapy.
             3.      Use of AFP as a tumor marker is not recommended in pregnant females.
             4.      AFP values regardless of levels should not be interpreted as absolute evidence for the
                     presence or absence of disease. All values should be correlated with clinical findings and
                     results of other investigations.
         Clinical Use
             ·       Useful for determining prognosis and monitoring therapy for Hepatocellular carcinoma. Level of
                     AFP is a prognostic indicator of survival. Elevated AFP and serum bilirubin levels in these
                     patients is associated with shorter survival time.
             ·       An aid in the management of Germ cell (Non-Seminomatous) tumors. Measurement of AFP
                     levels in combination with HCG levels are useful in classifying and staging Germ cell tumors
             ·       To predict tumor recurrence/presence of residual tumor
         Increased Levels
             ·       Germ cell (Non-Seminomatous) tumors
             ·       Primary hepatocellular carcinoma (70%)
             ·       Teratocarcinoma
             ·       Gastrointestinal tract cancers with or without liver metastasis
             ·       Benign hepatic conditions like Acute Viral Hepatitis, Chronic active hepatitis and Cirrhosis
             ·       Ataxia telangiectasia
             ·       Hereditary tyrosinemia
           Dr Himangshu Mazumdar                 Dr. Nimmi Kansal
           MD (Biochemistry)                     MD (Biochemistry)
           Consultant Biochemist - NRL           HOD Biochem & IA - NRL
    PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
                                                                                     *LPLT12358*                           Page 1 of 2
.
         LPL - PRODUCTION TEST COLLECTION
         CENTRE
         SECTOR - 18, BLOCK-E ROHINI
         DELHI 110085
         Name             :       Dummy-F001                                                               Collected            : 22/3/2018 7:34:00AM
                                                                                                           Received             : 22/3/2018 3:59:43PM
         Lab No.          :   LPLT12358            Age: 28 Years                  Gender:       Female     Reported             : 26/3/2018 1:35:03PM
         A/c Status       :   P                    Ref By :      ------------                              Report Status        :
         Test Name                                                                    Results                 Units                        Bio. Ref. Interval
          Result/s to follow:
          AFP (ALPHA FETOPROTEIN), TUMOR MARKER, SERUM
                                                                                IMPORTANT INSTRUCTIONS
          *Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
          *Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
          repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
          circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
          request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
          jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
          customer care Tel No. +91-11-39885050 for all queries related to test results.
    PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
                                                                                            *LPLT12358*                                       Page 2 of 2